Integrated Annual Report

Overview

The report presents PT Organon Pharma Indonesia Tbk's integrated annual and sustainability disclosures for 2025. The company reports strong growth, including net revenue of Rp1.226.482 million in its performance highlights and total revenue of 4,122,385,016 thousand Rupiah in the audited financial statements. Sustainability disclosures cover the full January-December period, including energy, water, waste, workforce and workplace-fatality data. The report also presents an ESG priorities matrix and describes oversight by the Board of Commissioners and sustainability governance arrangements.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English, Indonesian
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services